RASGRF1 and rheumatoid arthritis: IGF2BP3 improves the stability of the RASGRF1 mRNA to activate the RAS pathway, which activates mTORC1 to promote synovial cell proliferation and inflammatory activation, thereby aggravating joint injury in RA (Fig. 7i).